Hypera S.A. (OTCMKTS:HYPMY – Get Rating) was the recipient of a significant decline in short interest in June. As of June 30th, there was short interest totalling 800 shares, a decline of 75.0% from the June 15th total of 3,200 shares. Based on an average daily trading volume, of 14,000 shares, the short-interest ratio is currently 0.1 days.
Hypera Stock Performance
HYPMY stock traded up $0.18 during trading on Friday, reaching $7.36. 2,840 shares of the company were exchanged, compared to its average volume of 16,894. Hypera has a 52-week low of $4.63 and a 52-week high of $8.89. The company has a market cap of $4.66 billion, a P/E ratio of 17.52 and a beta of 0.77. The stock's 50 day moving average price is $7.59 and its 200 day moving average price is $6.96.
Get Hypera alerts:About Hypera
(Get Rating)
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.Featured Articles
- Get a free copy of the StockNews.com research report on Hypera (HYPMY)
- MarketBeat: Week in Review 7/11 – 7/15
- Is Coupang's Stock On The Verge Of A Turnaround?
- Should You Have These Two Banks In Your Portfolio?
- Verint Systems Stock is a Customer Engagement Play
- Why Shopify Stock Split...And is as Shoppable as Ever
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.